About HeaDS
HeaDS is a company based in Athens (Greece) founded in 2010 was acquired by Veeda Clinical Research in March 2024. The company has 902 employees as of November 04, 2024. HeaDS offers products and services including Preclinical Services, Clinical Trials, Bioanalytical Services, and Real World Evidence. HeaDS operates in a competitive market with competitors including Indegene, Zuellig Pharma, IntegriChain, Clinigen and Science Group, among others.
- Headquarter Athens, Greece
- Employees 902 as on 04 Nov, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Veeda Clinical Research Limited
- Jurisdiction Ahmedabad, Gujarat, India
-
Annual Revenue
$50.52 M (USD)43.36as on Mar 31, 2023
-
Net Profit
$5.1 M (USD)-15.92as on Mar 31, 2023
-
EBITDA
$12.43 M (USD)68.37as on Mar 31, 2023
-
Latest Funding Round
Not available
- Investors
-
Employee Count
902
as on Nov 04, 2024
-
Acquired by
Veeda Clinical Research
(Mar 26, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of HeaDS
HeaDS offers a comprehensive portfolio of products and services, including Preclinical Services, Clinical Trials, Bioanalytical Services, and Real World Evidence.
Supports drug discovery and IND submission processes.
Conducts phases I-IV trials for various therapeutics.
Handles method development and sample analysis for drugs.
Uses real-world data to improve trial recruitment and outcomes.
People of HeaDS
Unlock access to complete
Funding Insights of HeaDS
Detailed funding history for HeaDS
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in HeaDS
HeaDS has secured backing from 1 investor. Prominent investors backing the company include Veeda Clinical Research.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare.
|
Locked | Locked | Locked |
Investor details for HeaDS
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by HeaDS
Investment portfolio details for HeaDS
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - HeaDS
Detailed financials for HeaDS
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Heads Comparisons
Peer comparison for HeaDS
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of HeaDS
HeaDS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indegene, Zuellig Pharma, IntegriChain, Clinigen and Science Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Suite solutions are provided for payers and healthcare providers.
|
|
| Locked | Locked | Locked |
Healthcare access in Asia is enhanced by Zuellig Pharma.
|
|
| Locked | Locked | Locked |
Inventory, order and customer relationship management solution for life science suppliers.
|
|
| Locked | Locked | Locked |
Specialty medicines are supplied via clinical trials and access programs.
|
|
| Locked | Locked | Locked |
Technology-based consultancy and product development services are provided.
|
|
| Locked | Locked | Locked |
Strategic consulting services are provided to life sciences companies.
|
Detailed competitors of HeaDS
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Heads
Complete news archive for HeaDS
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about HeaDS
HeaDS was founded in 2010.
HeaDS is headquartered in Athens, Greece.
As of Nov 04, 2024, the latest employee count at HeaDS is 902.
Annual revenue of HeaDS is $50.52M as on Mar 31, 2023.
HeaDS was founded in 2010 and is based in Athens, Greece. Services in pharmacovigilance, regulatory affairs, and quality assurance are offered to clients in the pharmaceutical and healthcare sectors. Operations are centered on compliance support, risk management, and documentation processes. The company serves international markets through its domain heads-research.com, with a focus on regulatory submissions and safety monitoring. Expertise is applied to ensure adherence to global standards.
HeaDS's top competitors include Indegene, Zuellig Pharma and IntegriChain.
HeaDS offers Preclinical Services, Clinical Trials, Bioanalytical Services, and Real World Evidence.
HeaDS has 1 investor. Key investors include Veeda Clinical Research.